N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.

Ítems similars

• A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.
  per: Montastruc, J L, et al.
  Publicat: (1992)
• N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
  per: Olivares, David, et al.
  Publicat: (2012)
• Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
  per: Pawley, A. C., et al.
  Publicat: (1996)
• Subunit Arrangement in N-Methyl-d-aspartate (NMDA) Receptors
  per: Rambhadran, Anu, et al.
  Publicat: (2010)
• THE DISCRIMINATIVE STIMULUS EFFECTS OF N-METHYL-d-ASPARTATE GLYCINE-SITE LIGANDS IN NMDA ANTAGONIST-TRAINED RATS
  per: Nicholson, Katherine L., et al.
  Publicat: (2009)